Xuehan Mao

Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Acute lymphoblastic leukemia presenting as myocardial infiltration mimicking hypertrophic cardiomyopathy: a case report.

Acute lymphoblastic leukemia presenting as myocardial infiltration mimicking hypertrophic cardiomyopathy: a case report.

Journal: Frontiers in oncology
Published: June 17, 2026

Real-world efficacy and safety of golidocitinib in 3 patients with relapsed/refractory peripheral T-cell lymphoma.

Real-world efficacy and safety of golidocitinib in 3 patients with relapsed/refractory peripheral T-cell lymphoma.

Journal: Frontiers in oncology
Published: May 26, 2026

Myelopathy following intrathecal chemotherapy in a patient with acute lymphoblastic leukemia: a case report.

Myelopathy following intrathecal chemotherapy in a patient with acute lymphoblastic leukemia: a case report.

Journal: Frontiers in oncology
Published: April 10, 2026

The value of speckle tracking echocardiography in early identification of subclinical cardiac involvement in patients with multiple myeloma: a pilot retrospective study.

The value of speckle tracking echocardiography in early identification of subclinical cardiac involvement in patients with multiple myeloma: a pilot retrospective study.

Journal: Frontiers in medicine
Published: April 05, 2026

Acquired dysfibrinogenemia with discordant fibrinogen assays preceding the diagnosis of λ light-chain multiple myeloma: a case report.

Acquired dysfibrinogenemia with discordant fibrinogen assays preceding the diagnosis of λ light-chain multiple myeloma: a case report.

Journal: Thrombosis journal
Published: January 09, 2026

Type I Interferon Pathway Activation Disrupts Monocyte Maturation and Enhances Immune Evasion in Multiple Myeloma.

Type I Interferon Pathway Activation Disrupts Monocyte Maturation and Enhances Immune Evasion in Multiple Myeloma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 12, 2025

The age-dependent changes in risk weights of the prognostic factors for multiple myeloma.

The age-dependent changes in risk weights of the prognostic factors for multiple myeloma.

Journal: Hematology (Amsterdam, Netherlands)
Published: September 19, 2023

Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.

Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.

Journal: American journal of hematology
Published: May 26, 2023

Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment.

Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment.

Journal: Cancer research communications
Published: April 26, 2023

Case Report: Therapeutic Use of Ibrutinib in a Patient With Schnitzler Syndrome.

Case Report: Therapeutic Use of Ibrutinib in a Patient With Schnitzler Syndrome.

Journal: Frontiers in immunology
Published: March 11, 2022

Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment.

Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment.

Journal: Scientific reports
Published: August 12, 2020

1q21 gain but not t(4;14) indicates inferior outcomes in multiple myeloma treated with bortezomib.

1q21 gain but not t(4;14) indicates inferior outcomes in multiple myeloma treated with bortezomib.

Journal: Leukemia & lymphoma
Published: December 18, 2019
Showing 1-12 of 15

Last Updated: 09/26/2026